Inovio Pharmaceuticals
INO
#8803
Rank
NZ$0.26 B
Marketcap
NZ$3.87
Share price
-1.32%
Change (1 day)
22.05%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.95. In 2024 the company made an earnings per share (EPS) of NZ-$6.79 an increase over its 2023 EPS that were of NZ-$10.46.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-29.21%
2024NZ-$6.79-35.14%
2023NZ-$10.46-56.62%
2022NZ-$24.12-19.54%
2021NZ-$29.9835.9%
2020NZ-$22.06-11.57%
2019NZ-$24.9515.24%
2018NZ-$21.65-2.78%
2017NZ-$22.276.93%
2016NZ-$20.82134.88%
2015NZ-$8.87-29.51%
2014NZ-$12.58-57.34%
2013NZ-$29.48146.55%
2012NZ-$11.9620.83%
2011NZ-$9.90-29.41%
2010NZ-$14.02-48.48%
2009NZ-$27.2110%
2008NZ-$24.7411.11%
2007NZ-$22.27-41.3%
2006NZ-$37.94-66.91%
2005NZ-$114.63110.61%
2004NZ-$54.43-61.63%
2003NZ-$141.85186.67%
2002NZ-$49.48
2001N/A-100%
2000NZ-$39.59-63.64%
1999NZ-$108.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.96-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.94-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$2.15-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.65-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$13.05-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.18-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.20-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA